Advertisement Sohm Indian nutraceutical plant commences production - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sohm Indian nutraceutical plant commences production

Sohm, a generic pharmaceutical manufacturer, said that its new nutraceutical manufacturing facility in Ahmedabad, India has begun the commercial production of neutraceutical product line, including Diorac, a unique probiotic anti-diarrheal product.

The in house manufacturing plant helps to extend Sohm’s core competence to include neutraceutical at a right time when the United States Food & Drug Administration and the Indian Food & Drug Administration are simplifying regulations in regard to neutraceutical deliverables.

Sohm president and CEO Shailesh Shah said the new plant is in compliance with all Dietary Supplement Health and Education Guidelines.

The company has also received an endorsement and necessary regulatory compliances with local authority as well as with the Indian Food & Drug Administration and Food Standards Authority of India.